10x Genomics reports Q2 revenue $153.1M (+4% YoY), guides FY24 down to $640-660M; CFO resigns, Taich appointed

10x Genomics, Inc.

2024-Q2 EPS reported -$0.82 revenue$294,110,000

Q2 revenue $153.1M, +4% YoY; net loss $37.9M vs $62.4M loss in prior year.
Operating expenses down 10% to $146.0M; gross margin flat at 68%.
Full year 2024 revenue guidance lowered to $640-660M from $670-690M (3-7% growth).
CFO Justin McAnear resigns effective Aug 30; Adam Taich appointed CFO effective Aug 12.
Mennah Moustafa named Chief Commercial Officer effective Aug 1.

item 2.02 item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Justin J. McAnear

Chief Financial Officer

TXG · 10x Genomics, Inc.

Effective: 2024-08-30
Successor: Adam S. Taich
Filed: August 8, 2024, 7:59 PM ET

Justin J. McAnear, who on August 6, 2024 notified the Company of his intention to resign and who will continue to provide transition services as an employee of the Company through August 30, 2024.

Appointed

Adam S. Taich

Chief Financial Officer

TXG · 10x Genomics, Inc.

Effective: 2024-08-12
Filed: August 8, 2024, 7:59 PM ET

On August 8, 2024, the Company announced that Adam S. Taich will be joining the Company as its Chief Financial Officer, effective August 12, 2024, replacing Justin J. McAnear

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Justin J. McAnear resigned as Chief Financial Officer at 10x Genomics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Justin J. McAnear, who on August 6, 2024 notified the Company of his intention to resign and who will continue to provide transition services as an employee of the Company through August 30, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Adam S. Taich was appointed as Chief Financial Officer at 10x Genomics, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 8, 2024, the Company announced that Adam S. Taich will be joining the Company as its Chief Financial Officer, effective August 12, 2024, replacing Justin J. McAnear

View on SEC.gov

10x Genomics, Inc. filing history →

Source: SEC EDGAR

accession 0001770787-24-000058

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.